NCT05267288 2023-03-29
Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer
Qingdao Central Hospital
Phase 2 Unknown
Clinical Trials
17 trialsNCT03574402 2022-12-06
TRUMP
Guangdong Association of Clinical Trials
Phase 2 Unknown
NCT03239015 2022-03-04
Efficacy and Safety of Precision Therapy in Refractory Tumor
Shanghai Changzheng Hospital
Phase 2 Unknown
NCT04880811 2021-07-13
Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification
Peking University
Phase 2 Unknown
NCT04814056 2021-04-01
To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion
Shanghai Chest Hospital
Phase 4 Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04533321 2020-08-31
A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma
National University Hospital, Singapore
Phase 2 Unknown
NCT01746251 2020-07-07
Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
Massachusetts General Hospital
Phase 2 Unknown
NCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT03940976 2019-06-11
Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01)
Peking University
Phase 2 Unknown
NCT02353936 2019-02-11
A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus
Yonsei University
Phase 2 Unknown
NCT03810872 2019-01-22
An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation
AZ-VUB
Phase 2 Unknown
NCT02975141 2018-08-13
AFFECT
Ludwig-Maximilians - University of Munich
Phase 1 Unknown
NCT01728818 2017-07-19
ACCEPT
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT02511847 2016-04-15
Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib
National Taiwan University Hospital
Phase 2 Unknown
NCT01861223 2014-02-25
Afatinib Plus Nimotuzumb for NSCLC
Samsung Medical Center
Phase 1/2 Unknown
NCT01776684 2013-01-28
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Samsung Medical Center
Phase NA Unknown